Vutiglabridin for knee osteoarthritis: a phase 2 study
Part of Bones, joints & muscles clinical trials.
This trial tests an experimental pill called Vutiglabridin for people with knee osteoarthritis. It aims to see if the drug is safe and effective at reducing knee pain and improving function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have had knee pain for more than 3 months that requires treatment.
- An X-ray shows you have moderate knee osteoarthritis (grade 2 or 3).
- Your average knee pain in the last 24 hours is at least 50 out of 100 on a pain scale.
- You are not severely overweight (BMI below 35).
- You have not had knee surgery or received certain knee injections in the past few months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug given by vein that may block a protein linked to inflammation, which could help reduce knee pain and swelling. It is an early-stage trial to see if the drug is safe and feasible for people with knee osteoarthritis.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
This trial tests an injectable medication called RAB001 for people with knee osteoarthritis that hasn't improved with other treatments. The goal is to see if it's safe and helps reduce pain.
This trial tests a study drug called SL1002 to see if it reduces knee pain from osteoarthritis. It may be an option for people with chronic knee pain who haven't found enough relief from current treatments.
This study tests a new oral medication, Laybon Tab., for pain from knee osteoarthritis. It aims to see how well it works and how safe it is over time, potentially offering another treatment option for your knee pain.
This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.
Hear when a new Knee Osteoarthritis (Knee OA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.